Publication
Daraxonrasib in Pancreatic Cancer: From Second-Line Breakthrough to First-Line Evidence.
Sruthi Ranganathan, Timothée Olivier
Journal of clinical oncology : official journal of the American Society of Clinical OncologySep 3, 2026PMID 42691452doi:10.1200/JCO-26-01457 Journal ArticlepubmedProvenance
- Source
- PubMed
- Retrieved
- Sep 9, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-PUBMED-20260909-000004
Abstract
Abstract (excerpt)
Only the opening of the abstract is shown; abstract text may carry publisher copyright.
Data not yet available
No abstract stored. Read on PubMed
Linked entities
Linked entities (1)
How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.
Candidate 1
- cancerMalignant Pancreatic Neoplasmdictionary0.60
Curated evidence
Evidence citing this paper (0)
Data not yet available
No curated evidence item cites this publication.